drugset / Trial / NCT01648283

CYP2B6 Polymorphisms in Methadone Disposition

NCT01648283

NaSingle-groupOpen-labelOther

Summary

This research study will determine if genetic variation in CYP2B6 affects how the body metabolizes methadone.

Timeline

Start
2012-11
Primary completion
2015-03
Completion
2015-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Methadone Other / unclassified 6 mg Intravenous
Subject Methadone Other / unclassified 11 mg Intravenous

Indications

No indication recorded.